Emergent BioSolutions Inc.

Ownership Transactions Reported by 26 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	3	-52.2K	100%	$9.95	-$520K
Net	-3	-52.2K	-100%		-$520K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Fuad El-Hibri	Director	$2.44M			Dec 3, 2021
Jennifer Lynne Fox	EVP, Ext Aff, GC, Corp Sec	$1.52M			Jul 11, 2024
Richard S. Lindahl	EVP, Chief Financial Officer	$1.39M			Oct 15, 2024
Coleen Glessner	EVP, Quality & Ethics, and CPL	$1.3M			Dec 8, 2024
Donald W. DeGolyer	Director	$1.21M	-$273K	-18.4%	Nov 12, 2024
Robert Kramer	President and CEO, Director	$921K			Jun 9, 2023
Neal Franklin Fowler	Director	$787K			May 23, 2024
Marvin L. White	Director	$647K	-$171K	-20.9%	Nov 11, 2024
Louis W. Sullivan	Director	$605K			May 23, 2024
William Hartzel	SVP, Bioservices	$568K			Nov 11, 2024
Zsolt Harsanyi	Chairman, Director	$516K			May 23, 2024
Ronald Richard	Director	$411K			May 23, 2024
Sujata Tyagi Dayal	Director	$365K			May 23, 2024
Keith Katkin	Director	$346K			May 23, 2024
Kathryn C. Zoon	Director	$333K	-$75.8K	-18.6%	Jun 4, 2024
Adam Havey	EVP, Business Operations	$317K			Jun 9, 2023
Simon C. Lowry	Svp, R&D, Cmo	$266K			Dec 15, 2024
Paul Anthony Williams	SVP, Products Business	$198K			Jul 8, 2024
Atul Saran	EVP, Chief Strat & Dev Officer	$158K			Feb 28, 2023
Katherine Strei	EVP, Chief HR Officer	$114K			Feb 28, 2023
Jerome M. Hauer	Director	$105K			May 25, 2023
George A. Joulwan	Director	$73.2K			May 26, 2022
Jessica Perl	SVP, General Counsel, Corp Sec	$55.3K			Oct 29, 2024
Karen L. Smith	EVP, Chief Medical Officer	$21.6K			May 7, 2021
Joseph C. Papa	President and CEO, Director	$0			Mar 13, 2024
H. Haywood Miller III	Interim CEO				Jun 24, 2023

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.